Schutgens, Roger
Canadian Critical Care Trials Group
7 papers on CoChatORCID 0000-0002-2762-6033
Most cited papers
- Verified
Gene Therapy With Adeno-Associated Virus Vector 5-Human Factor IX in Adults With Hemophilia B
Miesbach, W., Meijer, K., Coppens, M., Kampmann, P., Klamroth, R., Schutgens, R., Tangelder, M., Castaman, G., Schwäble, J., Bonig, H., et al. (2018) · Blood
Hemophilia Treatment and ResearchVirus-based gene therapy research
Cited by 301
- Verified
Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial
Writing Committee for the REMAP-CAP Investigators, Abdelhady, H., Abdelrazik, M., Abdi, Z., Abdo, D., Abdulle, A., Abel, L., Abouzeenni, S., Abrahamson, G., Abusamra, Y., et al. (2021) · JAMA
COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research
Cited by 212
- Verified
Intravenous Vitamin C for Patients Hospitalized With COVID-19: Two Harmonized Randomized Clinical Trials
The LOVIT-COVID Investigators, O. B. O. T. C. C. C. T. G., Florescu, S., Stanciu, D., Zaharia, M., Kosa, A., Codreanu, D., Fareed, K., Kidwai, A., Kaye, C., Coutts, A., et al. (2023) · JAMA
Vitamin C and Antioxidants ResearchCOVID-19 Clinical Research Studies
Cited by 55
- Verified
Clinical characteristics associated with diagnostic delay of pulmonary embolism in primary care: a retrospective observational study
Hendriksen, J. M. T., Koster-van Ree, M., Morgenstern, M. J., Oudega, R., Schutgens, R. E. G., Moons, K. G. M., & Geersing, G.-J. (2017) · BMJ Open
Venous Thromboembolism Diagnosis and ManagementClinical Reasoning and Diagnostic Skills
Cited by 48
- Verified
Toward responsible clinical n-of-1 strategies for rare diseases
Defelippe, V. M., J.M.W. van Thiel, G., Otte, W. M., Schutgens, R. E. G., Stunnenberg, B., Cross, H. J., O'Callaghan, F., De Giorgis, V., Jansen, F. E., Perucca, E., et al. (2023) · Drug Discovery Today
Statistical Methods in Clinical TrialsBiomedical Ethics and Regulation
Cited by 30
- Verified
Stable FIX Expression and Durable Reductions in Bleeding and Factor IX Consumption for up to 4 Years Following AMT-060 Gene Therapy in Adults with Severe or Moderate-Severe Hemophilia B
Miesbach, W., Meijer, K., Coppens, M., Kampmann, P., Klamroth, D., Schutgens, R., Castaman, G., Seifried, E., Schwaeble, J., Bönig, H., et al. (2019) · Blood
Hemophilia Treatment and ResearchVirus-based gene therapy research
Cited by 27
- Verified
A feasibility study on two tailored interventions to improve adherence in adults with haemophilia
Hoefnagels, J. W., Fischer, K., Bos, R. A. T., Driessens, M. H. E., Meijer, S. L. A., Schutgens, R. E. G., & Schrijvers, L. H. (2020) · Pilot and Feasibility Studies
Hemophilia Treatment and ResearchMedication Adherence and Compliance
Cited by 24
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free